WHO approval of AstraZeneca unlikely to result in Irish U-tu

“I don’t think this means that Ireland is under pressure to reverse their decision, I think they’ll consider what they’re saying, but Ireland has access to three vaccines at the moment so we can consider who gets what,” Prof Lavelle told Morning Ireland.
“What they did was they looked at the immune responses [to the AstraZeneca vaccine], so they looked at the T cell and B cell responses in that trial across all age sectors and found that they were comparable in under 65s and over 65s. It’s not certainty, but in their minds it was predictive that it would be effective in over 65s.

Related Keywords

South Africa , Ireland , South African , Paddy Connolly , Ted Lavelle , Pfizer , Astrazeneca , Professor Of Immunology At Trinity College , World Health Organisation , Trinity College , Age Action Ireland , Prof Lavelle , South African Government , ஐயர்ல்யாஂட் , நெல் இணை , எட் லாவெல் , ஃபைசர் , ப்ரொஃபெஸர் ஆஃப் நோயெதிர்ப்பு இல் திரித்துவம் கல்லூரி , உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந் , திரித்துவம் கல்லூரி , வாழ்நாள் நடவடிக்கை ஐயர்ல்யாஂட் , ப்ரொஃப் லாவெல் ,